PATENT CLAIM ANALYSIS

Application Number: 15887655
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "400000"]

Abstract:
The invention provides liquid formulations containing buprenorphine, a pharmaceutically acceptable salt thereof, or a derivative thereof. The invention further provides liquid formulations containing buprenorphine and naloxone, pharmaceutically acceptable salts thereof or derivatives thereof. The invention further provides a method of treating pain or opioid dependence by administering liquid formulations containing buprenorphine or a combination of buprenorphine and naloxone, a pharmaceutically acceptable salt thereof, or a derivative thereof to a patient in need thereof.

Claim (Index 20):
A method of treating pain comprising administering the liquid formulation of  claim 1  to a patient in need thereof.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 88.0
- Lexical Diversity: 2.38235
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15246343', '14469063', '14923630', '15876553', '12221333']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7780053857827998
- 35 USC 102 Novelty (BERT): 0.5680964098661129
- Combined Prediction Score: 0.7570144881911312
- Mean Citation Score: 409.26965
- Max Citation Score: 485.124
- Similarity Product: 372.7080158743858

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test